<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">transmed</journal-id><journal-title-group><journal-title xml:lang="ru">Трансляционная медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Translational Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2311-4495</issn><issn pub-type="epub">2410-5155</issn><publisher><publisher-name>Almazov National Medical Research Centre, Saint Petersburg, Russia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/2311-4495-2025-12-1-17-26</article-id><article-id custom-type="edn" pub-id-type="custom">UXLPNN</article-id><article-id custom-type="elpub" pub-id-type="custom">transmed-970</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТКАНЕВЫЕ, КЛЕТОЧНЫЕ, ГЕНОМНЫЕ И ПРОТЕОМНЫЕ ТЕХНОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CELL, TISSUE, AND GENE THERAPY</subject></subj-group></article-categories><title-group><article-title>Новая технология дозревания ооцитов человека методом инъекции внеклеточных везикул фолликулярной жидкости доноров под блестящую оболочку женской гаметы</article-title><trans-title-group xml:lang="en"><trans-title>А new technology for maturation of human oo cytes by injection of extracellular vesicles of follicular donor fluid under the shiny shell of the female gamete</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8784-5502</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зингеренко</surname><given-names>Б. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zingerenko</surname><given-names>B. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зингеренко Борис Владимирович, младший научный сотрудник отделения вспомогательных технологий в лечении бесплодия им. проф. Б. В. Леонова</p><p>Москва</p></bio><bio xml:lang="en"><p>Boris V. Zingerenko, Junior Research Fellow, Department Assistive Technologies in Infertility Treatment</p><p>Moscow</p></bio><email xlink:type="simple">b_zingerenko@oparina4.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1396-7272</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макарова</surname><given-names>Н. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarova</surname><given-names>N. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Макарова Наталья Петровна, д.б.н., ведущий научный сотрудник отделения вспомогательных технологий в лечении бесплодия им. проф. Б. В. Леонова</p><p>Москва</p></bio><bio xml:lang="en"><p>Natalya P. Makarova, DSc, leading researcher, department of IVF named after Professor B. V. Leonov</p><p>Moscow</p></bio><email xlink:type="simple">np.makarova@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6502-4498</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сысоева</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Sysoeva</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сысоева Анастасия Павловна, к.б.н., эмбриолог отделения вспомогательных технологий в лечении бесплодия им. проф. Б. В. Леонова</p><p>Москва</p></bio><bio xml:lang="en"><p>Anastasia P. Sysoeva, PhD, Embryologist, Department of Assistive Technologies in Infertility Treatment</p><p>Moscow</p></bio><email xlink:type="simple">sysoeva.a.p@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0679-6818</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Евтушенко</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Evtushenko</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евтушенко Екатерина Алексеевна, к.б.н., старший преподаватель биологического факультета</p><p>Москва</p></bio><bio xml:lang="en"><p>Ekaterina A. Evtushenko, PhD, Senior Lecturer, Faculty of Biology</p><p>Moscow</p></bio><email xlink:type="simple">evtushenkoea@my.msu.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кулакова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulakova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кулакова Елена Владимировна, д.м.н., старший научный сотрудник отделения вспомогательных технологий в лечении бесплодия им. проф. Б. В. Леонова</p><p>Москва</p></bio><bio xml:lang="en"><p>Elena V. Kulakova, MD, senior researcher, department of IVF named after Professor B. V. Leonov</p><p>Moscow</p></bio><email xlink:type="simple">e_kulakova@oparina4.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8922-2878</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Калинина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalinina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Калинина Елена Анатольевна, д.м.н., профессор, заведующая отделением вспомогательных технологий в лечении бесплодия им. проф. Б. В. Леонова</p><p>Москва</p></bio><bio xml:lang="en"><p>Elena A. Kalinina, MD, PhD, professor, Chief of Department of Assistive Technologies in Infertility Treatment</p><p>Moscow</p></bio><email xlink:type="simple">e_kalinina@oparina4.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Academician V. I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Academician V. I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Московский государственный университет имени М.В. Ломоносова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В. И. Кулакова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Academician V. I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>07</day><month>05</month><year>2025</year></pub-date><volume>12</volume><issue>1</issue><issue-title>Внеклеточные везикулы: большие перспективы маленьких объектов</issue-title><fpage>17</fpage><lpage>26</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зингеренко Б.В., Макарова Н.П., Сысоева А.П., Евтушенко Е.А., Кулакова Е.В., Калинина Е.А., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Зингеренко Б.В., Макарова Н.П., Сысоева А.П., Евтушенко Е.А., Кулакова Е.В., Калинина Е.А.</copyright-holder><copyright-holder xml:lang="en">Zingerenko B.V., Makarova N.P., Sysoeva A.P., Evtushenko E.A., Kulakova E.V., Kalinina E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://transmed.almazovcentre.ru/jour/article/view/970">https://transmed.almazovcentre.ru/jour/article/view/970</self-uri><abstract><p>Актуальность. В программах вспомогательных репродуктивных технологий (ВРТ) не все ооциты, полученные при трансвагинальной пункции (ТВП), пригодны для оплодотворения, так как не все находятся на стадии МII. Ооциты на стадиях герминативного везикула (GV) и MI обычно утилизируются, поскольку после удаления кумулюсных клеток (КК) их дозревание и оплодотворение невозможны. В данном исследовании предложен метод дозревания таких ооцитов с помощью введения внеклеточных везикул (ВВ) фолликулярной жидкости (ФЖ) в перивителлиновое пространство. Цель. Оценить клиническую состоятельность технологии дозревания незрелых ооцитов без клеток кумулюса (стадии GV и MI) путем инъекции ВВ ФЖ донора под блестящую оболочку клетки. Материалы и методы. Собрано по 5 мл ФЖ от 4 доноров. Выделение ВВ ФЖ проводили методом последовательного центрифугирования. Часть везикул проанализировали с помощью метода анализа траекторий наночастиц (Nanoparticle Tracking Analysis, NTA), другую часть изучали с помощью трансмиссионной электронной микроскопии (ТЭМ). Отобрали 53 незрелых ооцита в основную группу и 18 в группу контроля. Инъекцию ВВ ФЖ до нора проводили через 4 часа после удаления КК, вводя под блестящую оболочку суспензию ВВ. Через 17 часов оценивали зрелость ооцитов в обеих группах. Результаты. Частота дозревания ооцитов в группе основной была статистически значимо выше, чем в группе сравнения, что свидетельствует о потенциальной эффективности метода EV-IVM для дозревания ооцитов на стадии GV. Заключение. Полученные данные дают надежду на разработку нового метода дозревания ооцитов в условиях in vitro.</p></abstract><trans-abstract xml:lang="en"><p>Background. In assisted reproductive technology (ART) programs, not all oocytes obtained during transvag inal puncture (TVP) are suitable for fertilization, as not all of them are at MII stage. Oocytes at germinal vesicle (GV) and MI stages are discarded because, after cumulus cells (CC) removal, their maturation and fertilization become impossible. Study proposes method for oocytes maturing by introducing extracellular vesicles (EVs) from follicular fluid (FF) into the perivitelline space. Objective. To evaluate the clinical feasibility of GV/MI oo cytes maturing technology without cumulus cells by injecting donor FF EVs under the zona pellucida. Materials and methods. FF (5 ml) was collected from 4 donors. EVs were isolated using sequential centrifugation. Portion of EVs was analyzed using Nanoparticle Tracking Analysis (NTA), while another portion was examined using transmission electron microscopy (TEM). Total of 53 immature oocytes were selected for the main group and 18 for the control group. Donor FF EVs were injected 4 hours after CC removal by introducing EVs suspension under zona pellucida. After 17 hours, oocyte maturity was assessed in both groups. Results. Oocytes maturation rate in the main group was statistically significantly higher than in the control group, indicating the potential effectiveness of the EV-IVM method for maturing GV-stage oocytes. Conclusion. Obtained data provide hope for the development of a new method for in vitro oocyte maturation.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>внеклеточные везикулы</kwd><kwd>экзосомы</kwd><kwd>фолликулярная жидкость</kwd><kwd>дозревание ооцитов</kwd><kwd>IVM</kwd><kwd>бесплодие</kwd><kwd>вспомогательные репродуктивные технологии</kwd></kwd-group><kwd-group xml:lang="en"><kwd>assisted reproductive technologies</kwd><kwd>exosomes</kwd><kwd>extracellular vesicles</kwd><kwd>follicular fluid</kwd><kwd>infertility</kwd><kwd>IVM</kwd><kwd>oocyte maturation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Silber SJ, Goldsmith S, Castleman L, Hayashi K. In Vitro Maturation, In Vitro Oogenesis, and Ovarian Longevity. Reprod Sci. 2024 May;31(5):1234–1245. DOI: 10.1007/s43032-023-01427-1. Epub 2023 Dec 30. PMID: 38160209; PMCID: PMC11090930.</mixed-citation><mixed-citation xml:lang="en">Silber SJ, Goldsmith S, Castleman L, Hayashi K. In Vitro Maturation, In Vitro Oogenesis, and Ovarian Longevity. Reprod Sci. 2024 May;31(5):1234–1245. DOI: 10.1007/s43032-023-01427-1. Epub 2023 Dec 30. PMID: 38160209; PMCID: PMC11090930.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Das M, Son WY. In vitro maturation (IVM) of human immature oocytes: is it still relevant? Reprod Biol Endocrinol. 2023 Nov 22;21(1):110. DOI: 10.1186/s12958023-01162-x. PMID: 37993914; PMCID: PMC10664544.</mixed-citation><mixed-citation xml:lang="en">Das M, Son WY. In vitro maturation (IVM) of human immature oocytes: is it still relevant? Reprod Biol Endocrinol. 2023 Nov 22;21(1):110. DOI: 10.1186/s12958023-01162-x. PMID: 37993914; PMCID: PMC10664544.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ho VN, Ho TM, Vuong LN, García-Velasco J. An update on the current indications for in vitro maturation. Curr Opin Obstet Gynecol. 2024 Jun 1;36(3):173–180. DOI: 10.1097/GCO.0000000000000942. Epub 2024 Jan 31. PMID: 38295060.</mixed-citation><mixed-citation xml:lang="en">Ho VN, Ho TM, Vuong LN, García-Velasco J. An update on the current indications for in vitro maturation. Curr Opin Obstet Gynecol. 2024 Jun 1;36(3):173–180. DOI: 10.1097/GCO.0000000000000942. Epub 2024 Jan 31. PMID: 38295060.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nejabati HR, Roshangar L, Nouri M. Follicular f luid extracellular vesicle miRNAs and ovarian aging. Clin Chim Acta. 2023 Jan 1;538:29–35. DOI: 10.1016/j.cca.2022.11.003. Epub 2022 Nov 8. PMID: 36368351.</mixed-citation><mixed-citation xml:lang="en">Nejabati HR, Roshangar L, Nouri M. Follicular f luid extracellular vesicle miRNAs and ovarian aging. Clin Chim Acta. 2023 Jan 1;538:29–35. DOI: 10.1016/j.cca.2022.11.003. Epub 2022 Nov 8. PMID: 36368351.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou Z, Zhang Y, Zhang X, et al. Follicular Fluid-Derived Small Extracellular Vesicles Alleviate DHEA-Induced Granulosa Cell Apoptosis by Delivering LINC00092. Reprod Sci. 2023 Oct;30(10):3092–3102. DOI: 10.1007/s43032-023-01251-7. Epub 2023 May 15. PMID: 37188981.</mixed-citation><mixed-citation xml:lang="en">Zhou Z, Zhang Y, Zhang X, et al. Follicular Fluid-Derived Small Extracellular Vesicles Alleviate DHEA-Induced Granulosa Cell Apoptosis by Delivering LINC00092. Reprod Sci. 2023 Oct;30(10):3092–3102. DOI: 10.1007/s43032-023-01251-7. Epub 2023 May 15. PMID: 37188981.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sysoeva AP, Makarova NP, Silachev DN, et al. Influence of Extracellular Vesicles of the Follicular Fluid on Morphofunctional Characteristics of Human Sperm. Bull Exp Biol Med. 2021 Dec;172(2):254–262. DOI: 10.1007/s10517-021-05372-4. Epub 2021 Dec 2. PMID: 34855079.</mixed-citation><mixed-citation xml:lang="en">Sysoeva AP, Makarova NP, Silachev DN, et al. Influence of Extracellular Vesicles of the Follicular Fluid on Morphofunctional Characteristics of Human Sperm. Bull Exp Biol Med. 2021 Dec;172(2):254–262. DOI: 10.1007/s10517-021-05372-4. Epub 2021 Dec 2. PMID: 34855079.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Neyroud AS, Chiechio RM, Moulin G, et al. Diversity of Extracellular Vesicles in Human Follicular Fluid: Morphological Analysis and Quantification. Int J Mol Sci. 2022 Oct 2;23(19):11676. DOI: 10.3390/ijms231911676. PMID: 36232981; PMCID: PMC9570429.</mixed-citation><mixed-citation xml:lang="en">Neyroud AS, Chiechio RM, Moulin G, et al. Diversity of Extracellular Vesicles in Human Follicular Fluid: Morphological Analysis and Quantification. Int J Mol Sci. 2022 Oct 2;23(19):11676. DOI: 10.3390/ijms231911676. PMID: 36232981; PMCID: PMC9570429.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gabryś J, Kij-Mitka B, Sawicki S, et al. Extracellular vesicles from follicular fluid may improve the nuclear maturation rate of in vitro matured mare oocytes. Theriogenology. 2022 Aug;188:116–124. DOI: 10.1016/j.theriogenology.2022.05.022. Epub 2022 May 27. PMID: 35689941.</mixed-citation><mixed-citation xml:lang="en">Gabryś J, Kij-Mitka B, Sawicki S, et al. Extracellular vesicles from follicular fluid may improve the nuclear maturation rate of in vitro matured mare oocytes. Theriogenology. 2022 Aug;188:116–124. DOI: 10.1016/j.theriogenology.2022.05.022. Epub 2022 May 27. PMID: 35689941.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Патент № 2807492 C1 Российская Федерация, МПК C12N 5/075, A61K 35/54. Технология дозревания ооцитов человека на стадии GV с помощью внеклеточных везикул фолликулярной жидкости в про граммах экстракорпорального оплодотворения: EV-IVM (extracellular vesicles in vitro maturation): № 2023101793: заявл. 27.01.2023: опубл. 15.11.2023 / Н. П. Макарова, А. П. Сысоева, Д. Н. Силачев [и др.]; заявитель Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В. И. Кулакова» Министерства здравоохранения Российской Федерации. EDN WEZOFP].</mixed-citation><mixed-citation xml:lang="en">Makarova NP, Sysoeva AP, Sylachev DN, et al. Technology for human oocyte maturation at Gv-stage using extracellular follicular fluid vesicles in fertilization programs in vitro:v-ivm (extracellular vesicles in vitro maturation) No 2023101793: date of filling: 27.01.2023: published: 15.11.2023. Proprietor(s): Federalnoe gosudarstvennoe byudzhetnoe uchrezhdenie “Natsionalnyj meditsinskij issledovatel`skij centr akusherstva, ginekologii i perinatologii imeni akademika V. I. Kulakova” Ministerstva zdravookhraneniya Rossijskoj Federatsii (RU) - EDN WEZOFP. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Министерства здравоохранения Российской Федерации от 31.07.2020 № 803н «О порядке использования вспомогательных репродуктивных технологий, противопоказаниях и ограничениях к их применению» (зарегистрирован 19.10.2020 № 60457). Текст: электронный // Официальный интернет-портал правовой информации: – URL: http://publication.pravo.gov.ru/Document/View/0001202010190041?.</mixed-citation><mixed-citation xml:lang="en">Order of the Ministry of Health of the Russian Federation (RU) 31.07.2020 No 803n “About the procedure for the use of assisted reproductive technologies, contraindications and restrictions to their use” (Registration 19.10.2020 No 60457). Text: web-site // Official Internet portal of legal information: – URL: http://publication.pravo. gov.ru/Document/View/0001202010190041?. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации. Женское бесплодие. 2024. Текст: электронный // Министерство здравоохранения Российской Федерации: официальный сайт. – URL: https://mosgorzdrav.ru/ru-RU/magic/default/download/14971.html (дата обращения: 01.12.2024).</mixed-citation><mixed-citation xml:lang="en">Clinical recommendations. Female infertility. 2024. Text: electronic // Ministry of Health of the Russian Federation: official website. – URL: https://mosgorzdrav.ru/ru-RU/magic/default/download/14971.html (data obrashcheniya: 01.12.2024). In Russian</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Welsh JA, Goberdhan DCI, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024 Feb;13(2):e12404. DOI: 10.1002/jev2.12404. Erratum in: J Extracell Vesicles. 2024 May;13(5):e12451. DOI: 10.1002/jev2.12451. PMID: 38326288; PMCID: PMC10850029.</mixed-citation><mixed-citation xml:lang="en">Welsh JA, Goberdhan DCI, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024 Feb;13(2):e12404. DOI: 10.1002/jev2.12404. Erratum in: J Extracell Vesicles. 2024 May;13(5):e12451. DOI: 10.1002/jev2.12451. PMID: 38326288; PMCID: PMC10850029.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kenigsberg S, Wyse BA, Librach CL, da Silveira JC. Protocol for exosome isolation from small volume of ovarian follicular fluid: evaluation of ultracentrifugation and commercial kits // Methods Mol. Biol. 2017. Vol. 1660. P. 321–341. DOI: 10.1007/978-1-4939-7253-1_26.</mixed-citation><mixed-citation xml:lang="en">Kenigsberg S, Wyse BA, Librach CL, da Silveira JC. Protocol for exosome isolation from small volume of ovarian follicular fluid: evaluation of ultracentrifugation and commercial kits // Methods Mol. Biol. 2017. Vol. 1660. P. 321–341. DOI: 10.1007/978-1-4939-7253-1_26.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zorova LD, Kovalchuk SI, Popkov VA, et al. Do Extracellular Vesicles Derived from Mesenchymal Stem Cells Contain Functional Mitochondria? Int J Mol Sci. 2022 Jul 3;23(13):7408. DOI: 10.3390/ijms23137408. PMID: 35806411; PMCID: PMC9266972.</mixed-citation><mixed-citation xml:lang="en">Zorova LD, Kovalchuk SI, Popkov VA, et al. Do Extracellular Vesicles Derived from Mesenchymal Stem Cells Contain Functional Mitochondria? Int J Mol Sci. 2022 Jul 3;23(13):7408. DOI: 10.3390/ijms23137408. PMID: 35806411; PMCID: PMC9266972.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Martinez CA, Rizos D, Rodriguez-Martinez H, Funahashi H. Oocyte-cumulus cells crosstalk: New comparative insights. Theriogenology. 2023 Jul 15;205:87 93. DOI: 10.1016/j.theriogenology.2023.04.009. Epub 2023 Apr 18. PMID: 37105091.</mixed-citation><mixed-citation xml:lang="en">Martinez CA, Rizos D, Rodriguez-Martinez H, Funahashi H. Oocyte-cumulus cells crosstalk: New comparative insights. Theriogenology. 2023 Jul 15;205:87 93. DOI: 10.1016/j.theriogenology.2023.04.009. Epub 2023 Apr 18. PMID: 37105091.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Nagyova E. The Biological Role of Hyaluronan Rich Oocyte-Cumulus Extracellular Matrix in Female Reproduction. Int J Mol Sci. 2018 Jan 18;19(1):283. DOI: 10.3390/ijms19010283. PMID: 29346283; PMCID: PMC5796229.</mixed-citation><mixed-citation xml:lang="en">Nagyova E. The Biological Role of Hyaluronan Rich Oocyte-Cumulus Extracellular Matrix in Female Reproduction. Int J Mol Sci. 2018 Jan 18;19(1):283. DOI: 10.3390/ijms19010283. PMID: 29346283; PMCID: PMC5796229.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Del Bianco D, Gentile R, Sallicandro L, et al. Electro-Metabolic Coupling of Cumulus-Oocyte Complex. Int J Mol Sci. 2024 May 14;25(10):5349. DOI: 10.3390/ijms25105349. PMID: 38791387; PMCID: PMC11120766.</mixed-citation><mixed-citation xml:lang="en">Del Bianco D, Gentile R, Sallicandro L, et al. Electro-Metabolic Coupling of Cumulus-Oocyte Complex. Int J Mol Sci. 2024 May 14;25(10):5349. DOI: 10.3390/ijms25105349. PMID: 38791387; PMCID: PMC11120766.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Machtinger R, Racowsky C, Baccarelli AA, et al. Recombinant human chorionic gonadotropin and gonadotropin-releasing hormone agonist differently affect the profile of extracellular vesicle microRNAs in human follicular fluid. J Assist Reprod Genet. 2023;40:527–536. https://doi.org/10.1007/s10815-022-02703-w</mixed-citation><mixed-citation xml:lang="en">Machtinger R, Racowsky C, Baccarelli AA, et al. Recombinant human chorionic gonadotropin and gonadotropin-releasing hormone agonist differently affect the profile of extracellular vesicle microRNAs in human follicular fluid. J Assist Reprod Genet. 2023;40:527–536. https://doi.org/10.1007/s10815-022-02703-w</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Piibor J, Dissanayake K, Midekessa G, et al. Characterization of bovine uterine fluid extracellular vesicles proteomic profiles at follicular and luteal phases of the oestrous cycle. Vet Res Commun. 2023;47:885–900. https://doi.org/10.1007/s11259-022-10052-3</mixed-citation><mixed-citation xml:lang="en">Piibor J, Dissanayake K, Midekessa G, et al. Characterization of bovine uterine fluid extracellular vesicles proteomic profiles at follicular and luteal phases of the oestrous cycle. Vet Res Commun. 2023;47:885–900. https://doi.org/10.1007/s11259-022-10052-3</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Aoki S, Inoue Y, Hara S, et al. microRNAs associated with the quality of follicular fluids affect oocyte and early embryonic development. Reprod Med Biol. 2024 Jan 18;23(1):e12559. DOI: 10.1002/rmb2.12559. PMID: 38239486; PMCID: PMC10795439.</mixed-citation><mixed-citation xml:lang="en">Aoki S, Inoue Y, Hara S, et al. microRNAs associated with the quality of follicular fluids affect oocyte and early embryonic development. Reprod Med Biol. 2024 Jan 18;23(1):e12559. DOI: 10.1002/rmb2.12559. PMID: 38239486; PMCID: PMC10795439.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Luis-Calero M, Marinaro F, et al. Characterization of preovulatory follicular fluid secretome and its effects on equine oocytes during in vitro maturation. Res Vet Sci. 2024 May;171:105222. DOI: 10.1016/j.rvsc.2024.105222. Epub 2024 Mar 11. PMID: 38513461.</mixed-citation><mixed-citation xml:lang="en">Luis-Calero M, Marinaro F, et al. Characterization of preovulatory follicular fluid secretome and its effects on equine oocytes during in vitro maturation. Res Vet Sci. 2024 May;171:105222. DOI: 10.1016/j.rvsc.2024.105222. Epub 2024 Mar 11. PMID: 38513461.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Nicolao MC, Rodriguez Rodrigues C, Cumino AC. Extracellular vesicles from Echinococcus granulosus larval stage: Isolation, characterization and uptake by dendritic cells. PLoS Negl Trop Dis. 2019;13(1):e0007032. https://doi.org/10.1371/journal.pntd.0007032</mixed-citation><mixed-citation xml:lang="en">Nicolao MC, Rodriguez Rodrigues C, Cumino AC. Extracellular vesicles from Echinococcus granulosus larval stage: Isolation, characterization and uptake by dendritic cells. PLoS Negl Trop Dis. 2019;13(1):e0007032. https://doi.org/10.1371/journal.pntd.0007032</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
